Why the New Insulin Available in Brazil’s Public Health System (SUS) is a Major Breakthrough
Brazil is embarking on a significant transformation in its public health approach to diabetes management. The Ministry of Health has officially begun transitioning patients within the Sistema Único de Saúde (SUS)—the country’s universal healthcare system—from the traditional human NPH insulin to a more modern alternative: insulin glargine. This shift represents a critical evolution in the … Read more
